Evidence map›Paper›PMID 21631215›Full record

ReviewNeurosurgical focus2011

Symptomatic intracranial arterial disease: incidence, natural history, diagnosis, and management.

Ananth K Vellimana, Andria L Ford, Jin-Moo Lee, Colin P Derdeyn, Gregory J Zipfel

Abstract readReview
In one paragraph

Review in Neurosurgical focus, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ananth K VellimanaDepartment of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Andria L Ford
Jin-Moo Lee
Colin P Derdeyn
Gregory J Zipfel

Funding

SAMMPRIS (Stenting vs. Aggressive Medical Management for Preventing . . .U01NS058728 · NINDS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI CHIMOWITZ, MARC IVOR · 2008 to 2011
$20.0M
Washington University SPOTRIAS Center - Stroke Trials Registry / Web InterfaceP50NS055977 · NINDS · WASHINGTON UNIVERSITY · PI LEE, JIN-MOO · 2008 to 2012
$10.1M
Washington University Institute of Clinical and Translational Sciences (KL2)KL2RR024994 · NCRR · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2007 to 2011
$8.6M
The Role of Cerebral Hemodynamics in Moya Moya DiseaseR01NS051631 · NINDS · WASHINGTON UNIVERSITY · PI DERDEYN, COLIN PIETER · 2006 to 2010
$1.6M
DEFINING THE ISCHEMIC PENUMBRA WITH MAGNETIC RESONANCE OXYGEN METABOLISMK23NS069807 · NINDS · WASHINGTON UNIVERSITY · PI FORD, ANDRIA LEE · 2011 to 2015
$872k
Untangling Amyloid Plaques With ProteasesR01NS067905 · NINDS · WASHINGTON UNIVERSITY · PI LEE, JIN-MOO · 2009 to 2010
$850k
NCRR NIH HHS 5KL2 RR024994NCRR NIH HHS KL2 RR024994NINDS NIH HHS K23 NS069807NINDS NIH HHS P50 NS055977NINDS NIH HHS R01 NS051631NINDS NIH HHS R01 NS067905NINDS NIH HHS R01 NS67905NINDS NIH HHS U01 NS058728NINDS NIH HHS U01 NS58728
6 · The paper itself

Abstract

Symptomatic intracranial arterial disease is associated with a high rate of recurrent ischemic events. The management of this condition is controversial, with some advocating medical therapy as a sole means of treatment and others recommending endovascular therapy in addition to best medical management. In rare cases, surgical intervention is considered. A thorough review of the available literature was performed, and treatment recommendations based on these data are provided.

Indexed as

Angioplasty, BalloonBrain IschemiaCerebral ArteriesCerebral RevascularizationDiagnostic ImagingFibrinolytic AgentsHumansIncidenceIntracranial ArteriosclerosisRadiographyStentsFibrinolytic Agents

Identifiers

PMID21631215
PMCPMC3593273

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.